Schedule 13G ownership disclosure

Pacific Biosciences of California Inc

COMMON STOCK · CUSIP: 69404D108

Event date: 2026-10-31

Filing-level shares
33,445,993
Percent of class
10.8%
  • T. Rowe Price Associates, Inc.

    Shares: 33,445,993 · Class: 10.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-26-000673
Form type
SCHEDULE 13G
Filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
CIK
CIK 1299130
Filed
Nov 06, 2026
Reporting period
Oct 31, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub